Skip to main content
. 2020 Nov 16;2020:8833637. doi: 10.1155/2020/8833637

Table 2.

The clinical characteristics of critically ill patients with CHF according to SAG levels.

Characteristics Serum anion gap (mmol/L) P value
<13 (n = 2334) ≥13, <16 (n = 2519) ≥16 (n = 2573)
Age (years) 72.2 ± 13.2 73.2 ± 13.2 72.5 ± 13.5 0.013
Gender, n (%) 0.278
 Male 1280 (54.8) 1332 (52.9) 1359 (52.8)
 Female 1054 (45.2) 1187 (47.1) 1214 (47.2)
Ethnicity, n (%) 0.002
 White 1744 (74.7) 1881 (74.7) 1821 (70.8)
 Black 152 (6.5) 187 (7.4) 230 (8.9)
 Other 438 (18.8) 451 (17.9) 522 (20.3)
SBP, mmHg 116.7 ± 15.2 117.6 ± 17.0 116.2 ± 17.8 0.004
DBP, mmHg 57.3 ± 9.4 58.0 ± 10.4 58.1 ± 10.9 0.013
MBP, mmHg 75.3 ± 9.7 76.1 ± 10.5 75.9 ± 11.1 0.038
HR, beats/minute 84.0 ± 14.2 84.0 ± 15.6 86.8 ± 16.7 <0.001
RR, beats/minute 18.7 ± 3.7 19.6 ± 3.9 20.2 ± 4.3 <0.001
Temperature, °C 36.8 ± 0.6 36.8 ± 0.6 36.7 ± 0.7 <0.001
SpO2, % 97.3 ± 1.9 96.9 ± 2.0 96.8 ± 2.4 <0.001
Weight, kg 81.9 ± 24.1 81.2 ± 24.3 81.3 ± 24.8 0.212
Scoring systems
 SOFA 4.5 ± 2.7 4.4 ± 2.8 5.7 ± 3.3 <0.001
 SAPSII 37.1 ± 11.6 38.6 ± 12.6 44.2 ± 14.0 <0.001
Dialysis, n (%) 60 (2.6) 115 (4.6) 440 (17.1) <0.001
Vasopressor, n (%) 558 (23.9) 498 (19.8) 666 (25.9) <0.001
Ventilation, n (%) 624 (26.7) 784 (31.1) 1000 (38.9) <0.001
ICU LOS, hours 116.7 ± 149.8 130.3 ± 164.5 147.4 ± 180.9 <0.001
30-day mortality, n (%) 254 (10.9) 399 (15.8) 665 (25.8) <0.001
90-day mortality, n (%) 411 (17.6) 579 (23.0) 882 (34.3) <0.001
Comorbidities, n (%)
 Liver diseases 97 (4.2) 89 (3.5) 119 (4.6) 0.144
 Renal failure 325 (13.9) 552 (21.9) 813 (31.6) <0.001
 Atrial fibrillation 1053 (45.1) 1134 (45.0) 1116 (43.4) 0.377
 Stroke 105 (4.5) 152 (6.0) 134 (5.2) 0.056
 AMI 121 (5.2) 207 (8.2) 270 (10.5) <0.001
 VHD 178 (7.6) 248 (9.8) 264 (10.3) 0.003
 PCD 130 (5.6) 140 (5.6) 139 (5.4) 0.959
 HBP 278 (11.9) 467 (18.5) 673 (26.2) <0.001
 Diabetes 786 (33.7) 846 (33.6) 1021 (39.7) <0.001
 Pneumonia 440 (18.9) 581 (23.1) 640 (24.9) <0.001
 Respiratory failure 487 (20.9) 628 (24.9) 774 (30.1) <0.001
 Malignancy 94 (4.0) 145 (5.8) 118 (4.6) 0.015
Laboratory tests
 WBC (K/μl) 11.4 ± 6.2 12.7 ± 27.8 13.8 ± 8.3 <0.001
 Platelet (K/μl) 196.2 ± 95.4 218.7 ± 98.2 240.1 ± 118.0 <0.001
 Hemoglobin (g/dl) 10.2 ± 1.9 10.8 ± 2.0 10.9 ± 2.1 <0.001
 Creatinine (mg/dl) 1.0 ± 0.6 1.4 ± 0.9 2.4 ± 2.0 <0.001
 BUN (mg/dl) 23.2 ± 13.7 30.0 ± 19.0 45.1 ± 28.8 <0.001
 Glucose (mg/dl) 129.0 ± 53.7 144.7 ± 60.9 171.3 ± 94.8 <0.001
 Sodium (mmol/L) 138.8 ± 4.6 138.9 ± 4.6 138.2 ± 5.4 <0.001
 Potassium (mmol/L) 4.1 ± 0.6 4.2 ± 0.7 4.4 ± 0.8 <0.001
 Chloride (mmol/L) 106.2 ± 6.2 104.6 ± 5.9 102.7 ± 6.6 <0.001
 Bicarbonate (mmol/L) 26.5 ± 4.9 24.8 ± 4.2 21.5 ± 4.7 <0.001
 PT (second) 15.9 ± 7.1 16.7 ± 9.9 17.8 ± 12.0 <0.001
Laboratory tests
 APTT (second) 38.7 ± 23.8 38.8 ± 25.2 40.4 ± 26.6 0.002
 Lactate, n (%) <0.001
  <1.7 mmol/L 1076 (46.1) 865 (34.3) 694 (27.0)
  ≥1.7 mmol/L 634 (27.2) 858 (34.1) 1306 (50.8)
  No test 624 (26.7) 796 (31.6) 573 (22.3)
 NT-proBNP, n (%) <0.001
  <4983 pg/ml 192 (8.2) 219 (8.7) 186 (7.2)
  ≥4983 pg/ml 118 (5.1) 200 (7.9) 280 (10.9)
  No test 2024 (86.7) 2100 (83.4) 2107 (81.9)

Note: CHF: congestive heart failure; SAG: serum anion gap; SBP: systolic blood pressure; DBP: diastolic blood pressure; MBP: mean blood pressure; RR: respiratory rate; HR: heart rate; SpO2: percutaneous oxygen saturation; SOFA: stroke, and malignancy. Calculate the sequential organ failure assessment score; SAPSII: simplified acute physiology score II; ICU: intensive care unit; LOS: length of stay; AMI: acute myocardial infarction; VHD: valvular heart diseases; PCD: pulmonary circulation diseases; HBP: hypertension; WBC: white blood cell; BUN: blood urea nitrogen; PT: prothrombin time; APTT: activated partial thromboplastin time; NT-proBNP: N-terminal probrain natriuretic peptide.